Drug Profile
HIV vaccine SeV-G-NP
Alternative Names: SeV-G; SeV-G(NP); SeV-G-NP vaccineLatest Information Update: 28 Jun 2020
Price :
$50
*
At a glance
- Originator DNAVEC Corporation; International AIDS Vaccine Initiative
- Developer ID Pharma; International AIDS Vaccine Initiative; Shenzhen SiBiono GeneTech
- Class AIDS vaccines; Viral vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported HIV infections
Most Recent Events
- 28 Jun 2020 No recent reports of development identified for preclinical development in HIV-infections in China (Intranasal)
- 16 Jul 2016 No recent reports of development identified for phase-I development in HIV-infections(In volunteers) in Kenya (Intranasal)
- 16 Jul 2016 No recent reports of development identified for phase-I development in HIV-infections(In volunteers) in Rwanda (Intranasal)